Relative survival is the standard measure of excess mortality due to cancer in population-based cancer survival studies. In relative survival analysis, the observed hazard for cancer patients is the sum of the expected hazard for the general cancer-free population and the excess hazard associated with a cancer diagnosis. Previous models for relative survival analysis have assumed that the excess hazard rate is related to covariates by additive or multiplicative regression models. In this paper, a transformation covariate regression model is developed for estimation of the excess hazard rate, which includes both the additive and the multiplicative regression models as special cases. The baseline excess hazard rate and time-dependent hazard ratios can be approximated by means of regression splines, and the parameter estimates can be obtained using a standard statistical package. As is demonstrated through simulation, the proposed transformation hazards model provides a reasonably good fit to typical relative survival data. For illustration purposes, the sex difference in relative survival for lung and bronchus cancer patients is examined using data from population-based cancer registries .
One of the most important methods for monitoring and evaluating the effectiveness of cancer patient care is cancer survival analysis using population-based cancer registry data. In population-based cancer survival analysis, patient survival is calculated for demographically defined groups so that the results are representative of the entire population-a perspective which is vital for the purpose of cancer control. The standard measure of excess mortality due to cancer is called "net survival," which is defined as the probability of survival among patients who would have survived a certain number of years after diagnosis in a hypothetical situation where the cancer under study was the only possible cause of death.
In clinical settings, net survival is often estimated by cause-specific survival, which requires accurate information on cause of death. In population-based cancer survival studies, the cause of death is often obtained via the death certificate. In this situation, it is often difficult or problematic to determine whether the cancer of interest is the primary cause of death (1) . An alternative measure of net survival is relative survival (2) , which is calculated as the observed survival for cancer patients divided by the expected survival of a comparable cancer-free population. Since a cohort of cancer-free individuals is difficult to obtain, we usually use expected life tables for the general population and assume that cancer deaths are a negligible proportion of all deaths. The main advantage of using relative survival is that it does not require information on cause of death, thus avoiding the problem of inaccuracy or nonavailability of death certificates.
Several approaches to the analysis of relative survival have been proposed (e.g., see Andersen et al. (3) , Dickman et al. (4) , Hakulinen and Tenkanen (5) , and Esteve et al. (6) , among others). Based on the formulation of the observed hazard for cancer patients, Stare et al. (7) and Pohar and Stare (8) classified the available approaches into 2 types of models: the additive hazards model and the multiplicative hazards model. Under the additive hazards model, the observed hazard of death for cancer patients (λ O ) is expressed as the sum of the expected hazard for the cancerfree population (λ E ) and the excess hazard due to cancer (λ C ), l O ðt; xÞ ¼ l E ðt; xÞ þ l C ðt; xÞ;
where the expected hazard λ E is derived on the basis of the life table for the general population, and where x includes both variables used to construct the life table (typically age, sex, and calendar time) and additional covariates that are related to cancer survival. Under the multiplicative hazards model (7, 8) , the observed hazard is specified as l O ðt; xÞ ¼ l E ðt; xÞl C ðt; xÞ;
where λ C (t, x) is a unit-free factor which can be seen as relative mortality due to cancer.
The multiplicative hazards model has fewer mathematical restrictions than the additive hazards model (7) . However, for population-based cancer survival studies, the additive hazards model for λ O is biologically more plausible and usually provides a better fit to the survival data than the multiplicative models (6, 9, 10) . Therefore, we only consider the additive hazards model for the observed hazard λ O here.
Let S O (t, x) and S E (t, x) denote the survival functions for cancer patients and the general population, respectively. The additive hazards model implies that the relative survival is S c (t, x) = S O (t, x)/S E (t, x). A primary interest in relative survival analysis is the effect of covariates x on the relative survival function S C (t, x), or equivalently on the excess hazard function λ C (t, x). Various regression models have been used for the excess hazard λ C (t, x). The focus of this paper is to develop a new class of regression models for the excess hazard λ C .
Likewise, the effects of covariates on λ C (t, x) could be multiplicative or additive. So far, most models assume that the effects of covariates are multiplicative, and thus provide estimates of hazard rate ratios (4, 5, 9, 11) . Multiplicative covariate regression models have been implemented in several R packages, for example, relsurv (8) and RSurv (11) . Originally proposed by Buckley (10) and Andersen et al. (3) , the additive covariate regression models have gained increasing popularity recently. They have proven to be a useful alternative to the multiplicative covariate models (12) . In some situations, the additive covariate regression models may yield a better fit to the relative survival data and provide useful information from a public health perspective. Based on previous work, a new class of transformation covariate regression models (TCRMs) is proposed for modeling the excess hazard, where the transformation is applied to the covariate effects. The proposed models include the additive and multiplicative covariate regression models as special cases, thus allowing direct comparison between the 2 special models.
MATERIALS AND METHODS

A TCRM for excess hazard
For a multiplicative covariate regression model, the excess hazard function is expressed as l C ðt; xÞ ¼ l 0 ðtÞexpðbxÞ; where λ 0 (t) is the baseline excess hazard function, β is the vector of regression coefficients, and x is the vector of covariates. The sign of the excess hazard is constrained by the sign of the baseline excess hazard. When the baseline excess hazard λ 0 (t) is nonnegative, the survival for cancer patients is always worse than that for a comparable cancer-free population. The additive covariate regression model assumes that l C ðt; xÞ ¼ l 0 ðtÞ þ bx:
In the additive covariate regression model, the excess hazard is directly modeled and the resulting covariate effects are easy to interpret. This formulation is especially useful for situations in which certain subgroups have excess hazard rates that are close to zero or slightly less than zero (12) . Although both models have been used for relative survival analysis, it is not straightforward to decide which model to use. As an extension, we construct a class of TCRMs for excess hazard through a power transformation (13) . We assume that the excess hazard satisfies the equation
where
is the Box-Cox transformation with parameter γ and the regression coefficient β represents the effect of x on the excess hazard. A positive value of β means that the excess hazard is higher for a larger value of x. The excess hazard can be calculated as
When γ = 1, this is an additive covariate regression model and the baseline excess hazard is λ 0 (t) = μ 0 (t); when γ = 0, this reduces to a multiplicative covariate regression model and λ 0 (t) = exp(μ 0 (t)). In the analysis, we impose the restriction that 0 ≤ γ ≤ 1. The baseline excess hazard λ 0 (t) can be piecewise constant (4) or totally unspecified as in the Cox model (14 For population-based cancer survival data, survival times are usually grouped into intervals ½t jÀ1; t j Þ; j ¼ 0; : : :; J, where t 0 = 0 is the beginning of the study and t J is the end of the follow-up period. Furthermore, cancer patients are stratified according to multiple categorical or continuous variables. Let x denote the covariate vector for a stratum. For the stratum indexed by x, let n xj denote the number of persons alive at the beginning of the jth interval. Let d xj and l xj denote the number of deaths and the number of persons lost to follow-up during the jth interval, respectively. If grouped survival data are based on annual intervals, then an approximation of the number of person-years at risk during interval j is y xj = n xj − (l xj + d xj )/2. This approximation relies on the assumption that death and censoring are evenly distributed throughout an interval (4). This assumption is generally valid except for the intervals shortly following cancer diagnosis. For malignant cancers with poor survival, the excess hazard due to cancer is usually high initially and then followed by a rapid decrease. In this situation, shorter intervals can be used at the start of follow-up (4). 
xÞ is the expected hazard and l C xj ¼ l C ðt j ; xÞ is the excess hazard due to cancer at time t j . The expected hazard can be calculated as l 
xj is a constant that does not depend on the parameters θ. The excess hazard can be calculated as
where μ j = μ 0 (t j ) is the transformed baseline excess hazard. When the value of γ is fixed, the Poisson distribution of d xj and the expression for l C xj imply a generalized linear model with a user-specified link function. The estimates of the parameters μ 1 , . . ., μ J and β can be obtained from the generalized linear model using standard statistical packages. A sample SAS macro (SAS Institute Inc., Cary, North Carolina) for fitting the TCRM is shown in the Appendix.
The maximum likelihood value for a fixed value of γ, denoted L(θ|γ), is actually a profile likelihood. The maximum likelihood estimate of γ is the value that maximizes L(θ|γ) for 0 ≤ γ ≤ 1. One can perform a grid search with respect to γ to obtain the profile maximum likelihood estimate. The actual computation time depends on how fine the grid is. For example, if the generalized linear model is fitted with a grid of 0.01, then the total computation time would be 100 times the time needed for a single generalized linear model. For a typical data set with 96 strata and 20 years of follow-up, the computation time with a grid of 0.01 is 121 seconds on a personal computer with an Intel Core i7 central processing unit (Intel Corporation, Santa Clara, California). The 100(1 − q)% confidence interval for γ includes the values such that
where L max is the maximum likelihood value and ðx 2 1 Þ À1 ðqÞ is the quantile function of a χ 2 distribution with 1 df.
Application
The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute is an authoritative source of information on cancer incidence and survival in the United States. The SEER registries routinely collect data on patient demographic characteristics, primary tumor site, morphology, stage at diagnosis, first course of treatment, follow-up for vital status, etc. Updated annually and provided as a public service in print and electronic formats, SEER data are used by thousands of researchers, clinicians, public health officials, legislators, policy-makers, community groups, and the public.
Women with lung and bronchus cancer appear to have better survival than men. Whether this sex difference in survival results from a better response to treatment, different tumor biology, or a longer life expectancy is not well understood. Wisnivesky and Halm (18) examined whether the sex difference in survival is related to different treatment options. They found that regardless of the type of treatment, women had better overall cancer-specific survival and better To account for the difference in relative survival by age group, I also included age group as a covariate. Therefore, I used 4 categorical variables-sex, age group, cancer stage, and grade-in the analysis. The SEER historical tumor stages were classified into the categories localized, regional, and distant. The patients were classified into 4 age groups: <45, 45-59, 60-74, and ≥75 years. The main effects included age, sex, stage, and grade. The interactions of sex with both stage and grade were used in the model in order to assess the effect of sex on survival by stage and grade. The baseline excess hazards and time-dependent hazard ratios for cancer stage and grade were approximated by means of regression splines. Because the initial hazards for lung and bronchus cancer patients were high in the first 2 years, I used half-year intervals for the first 2 years and annual intervals after 2 years. Therefore, the time intervals were 0, 0.5, 1, 1.5, 2, 3, . . . , 20 years.
To examine sensitivity to the number and location of knots, I fitted the TCRM with equally spaced knots while changing the number of knots from 2 to 4. The Bayesian Information Criterion (BIC) was used for model selection and comparison. Specifically, BIC was calculated as BIC = −2 log(L) + d × (log(n) + 1), where log(L) is the loglikelihood function, d is the degrees of freedom of the model, and n is the sample size. For survival data, there is no consensus on which number should be used for sample size. For continuous survival data, Volinsky and Raftery (19) suggested using the number of event times instead of the number of observations. Recently, Hashimoto et al. (20) examined the sensitivity of regression models for grouped survival data and used the number of observations for BIC calculation. In this analysis, I used the number of patients as the sample size. When the TCRM was fitted to the lung and bronchus cancer survival data, the maximum likelihood estimate of γ was 0.33 (95% confidence interval: 0.31, 0.36). I also fitted the multiplicative and additive excess hazards models. Note that the multiplicative and additive models are special cases of TCRMs with the transformation parameter γ fixed at 0 and 1, respectively. Because the value γ has to be estimated in the TCRM, it costs an additional degree of freedom. In all 3 submodels of TCRMs, the baseline hazards and time-dependent effects of cancer stage and grade were modeled by splines. For comparison, I fitted a nonproportional hazards model with piecewise constant baseline hazards. For the piecewise nonproportional hazards model, I also included interactions between intervals and stage and grade to model the nonproportional hazards (4). The BIC values for the 4 models are shown in Table 1 . We see that the BIC for the TCRM was 11,459.43, much smaller than that for the other 3 models. This showed that the TCRM was more parsimonious than the piecewise nonproportional hazards model with timedependent effects. By using one more transformation parameter, the TCRM provided a better fit than the multiplicative and additive excess hazards models. Table 2 shows the parameter estimates for sex by historical stage and grade. The estimates of sex difference remained approximately the same for different historical stages, while the sex differences diminished when the cancer grade increased from grade I to grade IV. For example, for localized lung and bronchus cancer, the sex difference in excess hazards was −0.2184 for grade I cancer and −0.0560 for grade IV cancer. In addition, younger patients had significantly lower relative hazards of dying from lung and bronchus cancer than older patients (P < 0.001). The sex-stage interaction was not significant (P = 0.8227), but the sexgrade interaction was highly significant (P < 0.001) (data not shown).
To examine visually the goodness of fit of the TCRM, I plotted the estimated and observed excess hazards due to lung and bronchus cancer for persons aged 60-74 years in Figure 1 . The black and white circles are the observed excess hazards for men and women, respectively. The solid and dashed lines show the estimated excess hazards for men and women, respectively. First, we see that the estimated excess hazards from the TCRM fit the observed hazards reasonably well. For both men and women, the excess hazard of cancer death decreases significantly in the first 5 years after diagnosis and then remains stable. This reveals a very important finding: that the first 5 years are the most crucial period for cancer patients. This also confirms that, from a public health perspective, it is reasonable to use the 5-year survival rate as a criterion with which to evaluate and compare cancer survival. Second, the excess hazard appears to increase and then decrease sharply, with a peak around the 1-year period for grade IV cancer. Third, the difference in survival between men and women diminishes as the cancer grade grows worse. This survival advantage of women over men is greatest for grade I cancer, where surgical treatment of lung and bronchus cancer offers a greater chance for a cure in women than in men. For the other age groups, we see similar trends in the sex difference by cancer stage and grade.
Simulation
I conducted a limited simulation study to examine the performance of the proposed model for grouped survival data. I considered 2 covariates. The first one was a binary covariate, x 1 = 0 or 1; for the second covariate, x 2 = 0, 1, 2, 3. According to the values of (x 1 , x 2 ), the survival data were stratified into 8 groups. In each group, the initial number of cancer cases was 1,000 or 5,000, which mimicked the annual incidences for moderately common and common cancer sites. The observed hazard of death for cancer patients was given by l
, where the expected hazards l E j were extracted from the US life tables (21) for people aged 65 + j years and the excess hazards were specified as Table 3 . 
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The baseline excess hazards μ j were generated to reflect the survival experience of persons with most cancers. Specifically, I considered Weibull models with μ j = aj
, where a is the shape parameter and b is the scale parameter. I set a = 0.75 and b = 3, 6, and 12, corresponding to median survival times of 1.8, 3.7, and 7.4 years, respectively. The plots of the baseline excess hazards are shown in Figure 2 . We can see that the initial excess hazards were high and that they dropped sharply during the first 2 years and then remained relatively stable afterwards. In addition, I set the transformation parameter to γ = 0, 0.5, and 1, and the regression coefficients (β 1 , β 2 ) are specified in the first column of Tables 3 and 4 according to the value of γ.
I calculated the empirical biases of the parameters β 1 , β 2 , and γ and the absolute biases of the excess hazards l The biases for the transformation parameter γ and the MAD for excess hazard l C xj are shown in Table 3 . For the transformation parameter γ, the magnitude of bias decreased when the number of cancer cases increased from 1,000 to 5,000, and the biases remained similar regardless of the specification of (β 1 , β 2 ). The bias for γ was positive when γ = 0 and negative when γ = 1. This was because the restricted range of γ was [0, 1]. When γ = 0.5, the empirical bias was close to 0. The magnitude of bias for γ decreased when the value of b increased from 3 to 12. The largest bias for γ occurred when γ = 1 and b = 3. For example, when n = 1,000, b = 3, and (γ, β 1 , β 2 ) = (1, 0.01, 0), the average bias for γ was −0.404. As shown in Figure 2 , the initial hazard was high when b = 3. This indicated that the estimate of γ from the proposed TCRM was negatively biased, especially when the initial excess hazard was high and the covariate effects on excess hazards were additive (γ = 1). When the covariate effects on excess hazards were not additive (γ = 0 or 0.5), the biases for γ were close to 0. Fortunately, the average biases for the estimates of excess hazardŝ l C xj were all below 0.002 (data not shown). This indicated that, although the estimates of γ were biased in certain situations, the estimates of excess hazards from the TCRM were rather accurate. The MAD forl C xj decreased when the number of cancer cases increased from 1,000 to 5,000, and the MAD remained similar for different values of (γ, β 1 , β 2 ). As Dickman et al. (4) suggested, when most deaths occur shortly after the diagnosis of cancer and the excess hazard changes rapidly, it is necessary to use shorter intervals early in the follow-up period.
The biases of the regression coefficients β 1 and β 2 are shown in Table 4 . We see that the biases for 5,000 cancer cases were smaller than those for 1,000 cases. Overall, the biases of the parameters β 1 and β 2 were reasonably small, especially when n = 5,000.
DISCUSSION
Relative survival is the standard measure of net survival due to cancer in population-based cancer survival analysis. In this article, I have proposed a new class of survival models based on the Box-Cox transformation for relative survival analysis. This class of covariate transformation models makes hazard-based regression more flexible, general, and versatile, and opens a wide family of relationships between covariates and excess hazards. The proposed model can be fitted using currently available statistical software.
In the analysis, survival times are grouped into half-year intervals in the first 2 years and annual intervals afterwards. This is because the hazards of lung and bronchus cancer death are highest in the first 2 years. Within each interval, the excess hazard is assumed to be constant. Different groupings of survival times may produce slightly different parameter estimates. It requires further work to investigate situations in which different grouping methods may affect the conclusion drawn (12) .
It is fairly common that nonproportional hazards are allowed in a multiplicative or additive hazards model (5, 7) . In these types of models, time-dependent hazard ratios can be reported for different follow-up intervals by using more parameters. Compared with models with time-dependent effects, the TCRM is more parsimonious and still allows a wide range of hazard structures while keeping the simple structures of the multiplicative and additive models at the same time. The TCRM can also allow time-dependent effects by using interactions between the spline terms and covariates. In addition, a single summary estimate of the hazard ratio for each covariate can be obtained from the TCRM (22) . This is useful for measuring or testing the overall covariate effect on survival. As we see from the application, the TCRM provides a better fit with a smaller BIC. In practice, however, analysts cannot inadvertently pick the TCRM over the commonly used multiplicative excess hazards model. One disadvantage of the TCRM is that the resulting parameters are usually difficult to interpret, except when γ = 0 or 1. When the primary aim is prediction or comparison of survival, the survival models with the best fit can be useful, especially in the projection of future cancer survival rates. Appropriate model selection technique and sensitivity analysis are necessary to pick the optimal model. Therefore, for the fixed value of γ, the transformation covariate regression model (TCRM) is actually a Poisson regression with a user-specified link function. Notice that the expected hazards l E xj are usually an increasing function of follow-up interval j, and excess hazards due to cancer h 1=g xj tend to decrease as a function of j; therefore, the sum l E xj þ h 1=g xj may not be a monotonic function of j. In this situation, SAS may give a warning.
The sample SAS macro for fitting a TCRM with regression splines for baseline excess hazard and with only main effects of covariates is shown below. ************************************ ; * Input data: dataName ************************************;
